Structural Modifications of Neuroprotective Anti-Parkinsonian (−)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): A...

por Modi, Gyan, Antonio, Tamara, Reith, Maarten, Dutta, Aloke
Publicado 2014

Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model

por Yedlapudi, Deepthi, Joshi, Gnanada S., Luo, Dan, Todi, Sokol V., Dutta, Aloke K.
Publicado 2016

Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementi...

por Yedlapudi, Deepthi, Xu, Liping, Luo, Dan, Marsh, Gregory B., Todi, Sokol V., Dutta, Aloke K.
Publicado 2019

A Rare Case of SARS-CoV-2 Infection Associated With Pituitary Apoplexy Without Comorbidities

por Ghosh, Ritwik, Roy, Dipayan, Roy, Devlina, Mandal, Arpan, Dutta, Aloke, Naga, Dinabandhu, Benito-León, Julián
Publicado 2021

Pharmacological and Behavioral Characterization of D-473, an Orally Active Triple Reuptake Inhibitor Targeting Dopamine, Serotonin and Norepinephrine Transporters

por Dutta, Aloke K., Santra, Soumava, Sharma, Horrick, Voshavar, Chandrashekhar, Xu, Liping, Mabrouk, Omar, Antonio, Tamara, Reith, Maarten E. A.
Publicado 2014